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Abstract
Background: India has the highest estimated burden of tuberculosis in the world, accounting for 21% of all tuberculosis
cases world-wide. However, due to lack of systematic analysis using multiple markers the available information on the
genomic diversity of Mycobacterium tuberculosis in India is limited.
Methodology/Principal Findings: Thus, 65 M. tuberculosis isolates from New Delhi, India were analyzed by spoligotyping,
MIRU-VNTR, large deletion PCR typing and single nucleotide polymorphism analysis (SNP). The Central Asian (CAS) 1 _DELHI
sub-lineage was the most prevalent sub-lineage comprising 46.2% (n=30) of all isolates, with shared-type (ST) 26 being the
most dominant genotype comprising 24.6% (n=16) of all isolates. Other sub-lineages observed were: East-African Indian
(EAI)-5 (9.2%, n=6), EAI6_BGD1 (6.2%, n=4), EAI3_IND, CAS and T1 with 6.2% each (n=4 each), Beijing (4.6%, n=3), CAS2
(3.1%, n=2), and X1 and X2 with 1 isolate each. Genotyping results from five isolates (7.7%) did not match any existing
spoligopatterns, and one isolate, ST124, belonged to an undefined lineage. Twenty-six percent of the isolates belonged to
the TbD1+ PGG1 genogroup. SNP analysis of the pncA gene revealed a CAS-lineage specific silent mutation, S65S, which
was observed for all CAS-lineage isolates (except two ST26 isolates) and in 1 orphan. Mutations in the pncA gene, conferring
resistance to pyrazinamide, were observed in 15.4% of all isolates. Collectively, mutations in the rpoB gene, the katG gene
and in both rpoB and katG genes, conferring resistance to rifampicin and isoniazid, respectively, were more frequent in
CAS1_DELHI isolates compared to non-CAS_DELHI isolates (OR: 3.1, CI95% [1.11, 8.70], P=0.045). The increased frequency of
drug-resistance could not be linked to the patients’ history of previous anti-tuberculosis treatment (OR: 1.156, CI95% [0.40,
3.36], P=0.79). Fifty-six percent of all new tuberculosis patients had mutations in either the katG gene or the rpoB gene, or
in both katG and rpoB genes.
Conclusion: CAS1_DELHI isolates circulating in New Delhi, India have a high frequency of mutations in the rpoB and katG
genes. A silent mutation (S65S) in the pncA gene can be used as a putative genetic marker for CAS-lineage isolates.
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Introduction
The Indian subcontinent has been a global hotspot for the
growth and spread of the TB epidemic in recent times [1] and has
served as the corridor of early world-wide dissemination of M.
tuberculosis during the ancient era [2]. Mycobacterium tuberculosis
genotypes from the Indian subcontinent have largely been
described using, in most cases, single techniques to define bacterial
diversity [3–7]. Such studies, although important, underestimate
the clonal diversity of M. tuberculosis.I S 6110 restriction-fragment
length polymorphism (RFLP) has been the gold standard for
population-based molecular epidemiological studies of TB with the
purpose of identifying pathways and predictors of ongoing TB
transmission [8,9]. However, some M. tuberculosis isolates, espe-
cially those belonging to ancient lineages, have few or no IS6110
copies [10,11]. Moreover, systematic fingerprinting of all M.
tuberculosis isolates by IS6110 RFLP is time-consuming, cumber-
some and the results have poor inter-laboratory portability
[10,12]. Thus, a combination of two rapid PCR-based molecular
typing methods; spoligotyping and variable number tandem
repeats of mycobacterial interspersed repetitive unit (MIRU-
VNTR) has become an attractive alternative to IS6110 RFLP. A
study by Hanekom et al [13] suggests that there are discriminatory
limitations to the available genotyping methods in high TB-
incidence areas and that the choice of appropriate MIRU-VNTR
loci require further investigation in diverse M. tuberculosis lineages
in low- and high TB-endemic countries. A few recent studies that
have analyzed tubercle bacilli from India using multiple markers
[2,14,15] reveal a clear predominance of two important
genogroups (TbD1
2 and TbD1
+ groups of strains), confined to
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+ East
African Indian (EAI) genofamily and the TbD1
2 hypervirulent
and multidrug-resistant (MDR) -associated Beijing strains pre-
dominates in the southern part of the country, the TbD1
2 Delhi
types, which, by spoligotyping are characterized by lack of at least
spacers 4–7 and 23–34 [16] are overwhelmingly represented in
Delhi and its adjoining states [7,17,18]. While EAI genotypes have
been dissected at genomic levels [14], no studies till date have been
performed to investigate the genetic composition of the Delhi
type/Central Asian (CAS) 1 isolates. Our study therefore, aimed at
analyzing the genetic makeup of circulating M. tuberculosis isolates
in metropolitan Delhi with an in-depth characterization of major
lineages and sub-lineages.
Materials and Methods
Patients and isolates
Following study approval by the Ministry of Health (reference:
V.21011/20/2002-CCD), India and the Lala Ram Sarup (LRS)
Institute of Tuberculosis and Respiratory Diseases, New Delhi,
isolates were obtained from pulmonary tuberculosis (TB) patients
attending the TB clinic of the LRS Institute. Sputum samples were
collected as part of the routine diagnostic examination of suspected
pulmonary TB patients at LRS. Verbal consent for analysis of M.
tuberculosis isolates from sputum samples were obtained from all
patients. Additionally, as part of the routine clinical examination at
the LRS Institute, information on current and previous history of
M. tuberculosis infection, history of contact with a TB case and a
history of receiving previous anti-tuberculosis treatment was
available. None of the study participants could be identified based
on the analyses undertaken on the M. tuberculosis isolates analyzed
in this study. Of 100 culture-positive acid-fast isolates, 23 isolates
were not viable upon sub-culturing. Of 77 isolates that were
available for this study, 9 were by the Hain’s kit (Hain Lifescience,
Nehren, Germany) and 16S rRNA sequencing found to be
atypical mycobacteria and excluded from further analyses. Thus,
isolates from 68 patients were included in this study. Forty-eight
percent of the patients included were male and the mean age was
30.6 years with 84.6% of the patients ,45 years of age. Twenty-
four (38.1%) patients were previously treated for TB.
DNA isolation
Chromosomal DNA was isolated as described by van Embden et
al [9] or by heat-extraction using a loopful of cells suspended in
200 ml of TE buffer (10 mM Tris-Cl, 1 mM EDTA), and heat-
killed by incubation at 95uC for 20 min. The supernatant
containing the extracted DNA was collected by centrifugation at
12000 rpm for 10 min.
Spoligotyping
Spoligotyping was performed with commercially available
activated Biodyne C membranes with the 43 synthetic oligonucle-
otides covalently bound to the membranes (Isogen Bioscience BV,
Maarssen, The Netherlands), as recommended by the manufactur-
er. The hybridization patterns were converted into binary and octal
formats according to Dale et al [19] and compared with previously
reported strains in the SpolDB4 [16] database.
MIRU-VNTR analysis
Isolates were genotyped by MIRU-VNTR by amplification of 15
loci as described by Supply et al [20]. PCR amplification was
performed in a total volume of 20 ml containing 1 ml DNA, 0.04–
0.4 mM of all 15 primer sets, and Hotstart Taq Plus polymerase
Master Mix (Qiagen). All reactions were subjected to 95uC for
5 min, followed by 30 cycles of 30 sec at 95uC, 1 min at 55uC,
1.5 min at 72uC and terminated by 7 min at 72uC. Genotyping was
performed using multiplex PCR with a Rox-labeled MapMarker
1000 size standard (PE Applied Biosystems) for sizing of the PCR
products. The PCR fragments were analyzed using a capillary-
based electrophoresis sequencer (ABI 3700), and sizing of the
various VNTR alleles were done using the Peak Scanner Software
v1.0 (PE Applied Biosystems). The number of repeats present in
each locus was determined and alleles were assigned numerical
values accordingly. Furthermore, isolates with identical MIRU-
VNTR genotype were defined as belonging to the same cluster.
Single Nucleotide Polymorphisms
Isolates were assigned to Principal Genetic Groups (PGG) after
PCR and subsequent SNP analysis of katG
463 and gyrA
95 using
primers as described in Sreevatsan et al [21] (Table 1). Other
mutations in the rpoB, embB, katG, pncA and gyrA genes of the M.
tuberculosis isolates were determined by PCR and sequencing using
primers listed in Table 1. PCR was performed in 20 ml reactions
containing 12.5 ml Taq Polymerase (GoTaq Mastermix, Pro-
mega), 0.04 mM of each primer, 9.5 mlH 2O and 1 ml DNA. The
PCR reaction consisted of an initial 2 min for denaturation at
95uC, 30 cycles of 95uC for 1 min, 55–65uC, for 1 min, 72uC for
2 min and elongation time of 72uC for 5 min. Sequencing reaction
consisted of an initial 5 min for denaturation at 96uC, 25 cycles of
96uC for 15 sec, 50uC for 10 sec, 60uC for 4 min and elongation
time of 72uC for 15 min using the BigDye 3.1 Terminator Cycle
Sequencing Kit (Applied Biosystems Inc). The sequencing was
carried out in an ABI 377 automatic DNA sequencer (Applied
Biosystems Inc., Foster, CA) and nucleotide sequences were
analyzed using DNASTAR software (DNASTAR, Inc., USA).
An isolate was defined as being MDR if mutations in both the
rpoB and katG genes were observed.
TbD1 analysis
The presence or absence of TbD1 was analyzed by PCR using 2
primer sets complementary to the sequences of the deleted region
or complementary to the internal sequences of the intact region
[22]. Isolates containing the TbD1 region (TbD1+) produced a
PCR product using the internal primers, whereas isolates that
lacked the TbD1 region (TbD12) produced a PCR product using
the flanking primers only.
Cluster analysis
All results from this study were entered into the Bionumerics
program (Bionumerics version 3.1, Applied Maths, Saint-Martens-
Latem, Belgium). A dendrogram of the MIRU-VNTR profiles
were produced following Pearson correlation and unweighted pair
group method with arithmetic average analysis.
Statistical analysis
The Hunter-Gaston discriminatory index (HGDI) was calcu-
lated for each of the 15 MIRU-VNTR loci as described previously
[23]. The discriminatory nature of each loci were, based on HGDI
values, considered as highly .0.6, moderately 0.3–0.6 and poorly
,0.3 as suggested by Sola et al. [24]. Differences between
proportions were analyzed using the chi-square exact test (with
Yates’ correction for continuity) and expressed as odds ratios
(ORs) with 95% confidence interval (95%CI). The patient’s
history of previous anti-TB treatment was taken into consideration
when assessing a link between mutations conferring anti-TB drug-
resistance and the CAS1_DELHI sub-lineage isolates using simple
and multivariable logistic regression analyses using SPSS version
TB Molecular Typing
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statistical significance.
Results
MIRU-VNTR
Of the 68 isolates analyzed by MIRU-VNTR, 3 isolates were
suspected to be of mixed M. tuberculosis sub-populations and were
excluded from further analysis. Of the remaining 65 isolates, 21
isolates could, by MIRU-VNTR, be distributed into 10 clusters.
Three clusters comprising 6 isolates could be discriminated by
SNP analysis of katG/rpoB genes. Two clusters comprising 2
isolates each could be further discriminated by spoligotyping,
whereas in one cluster comprising 3 isolates, two isolates of the
same genotype were discriminated by SNP analysis of rpoB/embB
genes. The third isolate in this cluster belonged to a different
shared-type (Figure 1). Eight isolates comprising 4 clusters could
not be discriminated by a combination of MIRU-VNTR and SNP
analyses of katG, rpoB, embB,o rpncA. No epidemiologic link could
be established between the patients. MIRU26 was the most
discriminatory locus for isolates belonging to the CAS1_DELHI
sub-lineage with a HGDI value of 0.788506, whereas QUB-26
was the most discriminatory locus for EAI5 isolates with a HGDI
of 0.8. MIRU-VNTR discriminated only moderately between
isolates of the EAI6_BGD1 sub-lineage with ETR-A and QUB-
4156c giving the highest HGDI value of 0.5.
Spoligotyping
Sixty-five isolates from New Delhi were analyzed by spoligotyp-
ing and the results compared to the shared-types (ST) and
lineages/sub-lineages described in SpolDB4 [16]. Of the 65
isolates with single M. tuberculosis sub-population, 60 were assigned
to 21 previously described ST’s belonging to 10 different sub-
lineages (Table 2). CAS1_DELHI (n=30) was the most dominant
sub-lineage and ST26 (CAS1_DELHI) the most frequent
genotype (24.6%, n=16). Other sub-lineages observed in this
study were EAI5 (9.2%, n=6), EAI6_BGD1 (6.2%, n=4),
EAI3_IND (6.2%, n=4), CAS (6.2%, n=4), T1 (6.2%, n=4),
Beijing (4.6%, n=3), CAS2 (3.1%, n=2), and 2 isolates belonged
to X1 and X2, respectively. Five isolates (7.7%) were not described
previously and were termed orphans, and 1 isolate (ST124)
belonged to a previously undesignated lineage (Table 2).
Single Nucleotide Polymorphism Analysis
PCR and subsequent SNP analysis was performed on 65 isolates
for the genes katG
364 and gyrA
95. Eight isolates (12.3%) had a point-
mutation at position katG
463, whereas no mutations were observed
for gyrA
95 and hence, the isolates were assigned to PGG2. Six of
the 8 isolates with a mutation in katG
463 belonged to the T1 (n=4),
X1 (n=1) and X2 (n=1) sub-lineages, whereas 2 isolates belonged
to previously undescribed lineages. All other isolates (87.7%)
analyzed were assigned to the genogroup PGG1 (Figure 1,
Table 3). SNP analysis was also performed for 4 genes know to be
involved in resistance to the anti-TB drugs isoniazid [INH] (katG),
rifampicin [RIF] (rpoB), ethambutol (embB) and pyrazinamide
[PZA] (pncA). The point-mutations observed for all 4 genes are
described in Table 3. Thirty-two isolates had a mutation in at least
the rpoB gene of which 23 had combined katG and rpoB mutations
(MDR-TB). Of the 23 MDR-TB isolates, 11 belonged to the
CAS1_DELHI sub-lineage, 3 to the Beijing lineage, 3 to the
EAI3_IND sub-lineage, 2 to the CAS lineage, 2 to the EAI5 sub-
lineage, 1 to the CAS2 sub-lineage, and 1 to the X2 sub-lineage.
Nine isolates had combined mutations in the katG, rpoB and embB
genes. Three isolates had a mutation in the katG gene only,
whereas 1 isolate had combined katG and embB mutations. Of the
10 isolates with a mutation in the pncA gene conferring resistance
to PZA, 7 also had mutations in both rpoB and katG, 1 isolate had
mutations in rpoB and embB, whereas the 2 remaining isolates with
a pncA mutation were wild-type for the other 3 genes analysed.
One isolate had a mutation in the embB gene only.
The most frequently observed mutation was a silent C-.T
mutation in codon 65 of the pncA gene. This mutation was
observed in all but two isolates of the CAS lineage and in 1
orphan, whereas none of the other isolates had this mutation
(Table 3, Figure 1). The most frequently observed mutation in katG
was a G-.C substitution at position 944, resulting in an S315T
substitution in 22 isolates. Twelve isolates had a C-.T mutation in
position 1350 of rpoB, resulting in an S531L substitution, whereas
6 isolates had an A-.G mutation at position 917 in embB, causing
an M306I substitution (Table 3).
Mutations in the rpoB gene, the katG gene, and in both rpoB and
katG genes were together more frequent in CAS1_DELHI isolates
compared to non-CAS_DELHI isolates (OR: 3.1, CI95% [1.11,
8.70], P=0.045). However, the increased frequency of drug-
resistance observed for the CAS1_DELHI sub-lineage isolates was
not linked the patients’ history of previous anti-TB treatment (OR:
1.156, CI95% [0.40, 3.36], P=0.79).
TbD1 analysis. All isolates were analyzed for the presence or
absence of the TbD1 region by PCR. Seventeen isolates belonging
to EAI5 (ST38, n=6), EAI6_BGD1 (ST1409, n=4), EAI3_IND
(ST11, n=4) and three orphans belonging to previously
undescribed lineages had this region intact, whereas all other
isolates lacked this region. All isolates with an intact TbD1
belonged to the PGG1 genogroup (Figure 1).
Table 1. Primers used for the analysis of single nucleotide polymorphisms in 65 M. tuberculosis isolates from New Delhi, India.
Gene Forward (59-.39) Reverse (59-.39) References
pncA GTCGGTCATGTTCGCGATCG GCTTTGCGGCGAGCGCTCCA [43]
katG CATGAACGACGTCGAAACAG CGAGGAAACTGTTGTCCCAT [45]
rpoB GGTCGGCATGTCGCGGATGG GCACGTCGCGGACCTCCAGC [46]
embB CGGCATGCGCCGGCTGATTC TCCACAGACTGGCGTCGCTG [47]
katG
463 CGAGGAATTGGCCGACGAGTT CGGCGCCGCGGAGTTGAATGA [21]
gyrA
95 CAGCTACATCGACTTGCGA GGGCTTCGGTGTTACCTCAT [21]
TbD1 flanking CTACCTCATCTTCCGGTCCA CATAGATCCCGGACATGGTG [22]
TbD1 internal CGTTCAACCCCAAACAGGTA AATCGAACTCGTGGAACACC [22]
doi:10.1371/journal.pone.0004540.t001
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PLoS ONE | www.plosone.org 3 February 2009 | Volume 4 | Issue 2 | e4540Figure 1. Diversity of 65 M. tuberculosis isolates from New Delhi, India deduced from MIRU-VNTR, spoligotyping and single
nucleotide polymorphism analyses. MIRU-VNTR clusters that could be discriminated by spoligotyping are highlighted in blue and clusters that
could be discriminated based on mutations in the katG, rpoB and/or embB genes are highlighted in yellow. Clusters that could not be discriminated
using a combination of all markers are highlighted in green. The dendrogram was produced following Pearson correlation and unweighted pair
group method with arithmetic average analysis.
doi:10.1371/journal.pone.0004540.g001
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Genomic plasticity and phenotypic versatility of pathogenic
bacteria are the two major forces that stratify potentially virulent
and benign types [25]. Our understanding of mycobacterial
evolution is partly based on this paradigm where pathogenic
‘specialist’ forms are thought to have evolved from their
‘generalist’ predecessors [26]. While globally, the core gene pools
of such bacteria are highly clonal [21], there may be certain plastic
regions that experience frequent genomic recasting [22]. Accurate
analysis of the repertoire of such elements in a given population
based on multiple genome profiling approaches could reveal
significant aspects of ongoing evolution (and transmission) and the
available magnitude of genetic diversity among the strains could
thus be unraveled. This ultimately helps one understand
transmission cum virulence potentials of strains and should ideally
constitute an important agenda for epidemic control programs.
M. tuberculosis strains of the so called PGG1 [21] have been
prevalent in India with CAS (TbD1
2) and EAI (TbD1
+) being the
major genogroups. While EAI strains have been the focus of
attention for some time owing to their presumed ‘low virulent’
characteristics [27,28] and their links to ancestral African
predecessors [21,29], the origins and routes of the spread of the
CAS strains are not clear. Although these lineages are prevalent in
countries of Central- and West-Asian regions it is not evident why
they are specifically predominant in the Delhi region. Despite the
characteristic deletion of the TbD1 region, CAS strains have never
been linked to any institutionalized outbreaks as seen for example
in the case of the TbD1
2 Beijing-lineage isolates [3,30]. The
spread of the CAS strains through the western corridors and
subsequent adaptation to the North Indian populations is an
imminent possibility. However, more in-depth analyses involving
multiple genetic loci are essential in order to delineate the origin
and spread route of the CAS strains. Our study was partly
undertaken with this objective.
The genotypic analyses employed in this study showed that the
majority of isolates (73.8%) belonged to the TbD1
2 PGG1
genogroup, whereas only 26.2% belonged to lineages with an
intact TbD1 region. The relatively low number of TbD1
+ isolates
observed in this study is in line with previous studies from other
parts of North India, which show a predominance of TbD1
2
Table 2. Shared-type and lineage/sub-lineage distribution of
65 M. tuberculosis isolates from New Delhi, India.
Lineage/Sub-lineage ST no.
No. of
isolates
Total no. of
isolates (%)
CAS1_Delhi 26 16 30 (46.2)
25 5
141 4
381 2
1327 1
1343 1
1344 1
EAI5 138 6 6 (9.2)
EAI6_BGD1 1409 4 4 (6.2)
EAI3_IND 11 4 4 (6.2)
CAS 357 1 4 (6.2)
952 1
1264 1
1616 1
T1 1877 2 4 (6.2)
53 1
1233 1
Beijing 1 3 3 (4.6)
CAS2 288 2 2 (3.1)
X1 1394 1 1 (1.5)
X2 137 1 1 (1.5)
Previously undescribed Orphan 5 5 (7.7)
Previously undesignated ST124 1 1 (1.5)
doi:10.1371/journal.pone.0004540.t002
Table 3. Number of single nucleotide polymorphisms
observed for the 6 regions of interest in 65 M. tuberculosis
isolates from New Delhi, India.
Gene Mutation
No. of isolates
with mutation
katG G-.C pos 944, S315T 22
G-.A pos 944, S315N 3
G-.A pos 836, G279D 1
G-.A pos 946, R316Q 1
A-.C pos 970, T324P 1
rpoB C-.T pos 1350, S531L 12
A-.G pos 1335, H526D 4
A-.T pos 1305, D516V 4
C-.T pos 1334, H526D 3
G-.T pos 1304, D516V 3
T-.C pos 1356, L533P 2
C-.A pos 1334, H526N 1
C-.G pos 1334, H526D 1
C-.G pos 1350, S531L 1
C-.A pos 1273, F505L 1
T-.C pos 1290, L511P 1
C-.A pos 1295, Q513K 1
embB A-.G pos 917, M306I 6
G-.A pos 919, M306I 3
A-.C pos 917, M306L 2
A-.C pos 957, Y319S 1
G-.A pos 949, M316I 1
G-.C pos 919, M306I 1
pncA C-.T pos 195, S65S 35
A-.C pos 535, S178R 2
A-.C pos 35, D12A 1
Del C pos 344, STOP116 1
Del G pos 166, STOP116 1
Ins G pos 234, STOP126 1
Ins G pos 394, Frameshift 1
T-.C pos 104, L34P 1
G-.C pos 357, W119C 1
G-.C pos 481, A160P 1
katG
463 CTG-.CGG pos 463 8
gyrA
95 No mutations observed -
doi:10.1371/journal.pone.0004540.t003
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dominated by TbD1
+ strains [2,7,14,18,31]. Spoligotyping results
from this study confirmed previous studies [5,18,32] which show
that the CAS1_DELHI sub-lineage dominates in the Delhi region
and that ST26 is one of the most frequently observed genotypes in
this area.
Strains of the ST1 genotype (Beijing lineage) are reportedly the
most prevalent genotype world-wide [16]. In contrast to other
urban areas inSouth-East Asia [33], forthis study,only4.6% (n=3)
of the isolates belonged to the ST1 genotype compared to 24.6%
(n=16) of ST26 genotype. The low frequency of Beijing isolates in
this region is in concordance with other studies from Karachi,
Pakistan [34] and Delhi, India [7]. Like isolates of the hypervirulent
and MDR-associated ST1 genotype, the ST26 isolates belong to the
TbD1
2 PGG1 genogroup. Isolates of the Beijing lineage have been
shown to be less prevalent in North India compared to the central
andsouthernparts[18].AllST1isolatesand 31.3%ofST26isolates
in this study had mutations in at least the rpoB and katG genes.
Unlike the higherfrequencyof MDRreported for isolatesbelonging
to the ST1 genotype, no significant increase in the frequency of
combined mutations in the rpoB and katG genes in the ST26
genotype could be established. Furthermore, in agreement with
previously published results [4,34], isolates belonging to the CAS1
sub-lineages did not show an increased rate of MDR. However, our
study showed that mutations conferring resistance to both RIF and
INH, key first-line anti-TB drugs, were more frequent in
CAS1_DELHI isolates compared to non-CAS_DELHI isolates
(OR: 3.1, P=0.045).Mutations(deletions and insertions) in the rpoB
and katG genes are considered to be synonymous with resistance to
RIF [35] and INH [36], respectively. The estimated frequency of
spontaneous mutations conferring resistance to INH are 3.5610
26
and 3.1610
28 for RIF [37]. The risk of a double spontaneous
mutation is very low, estimated to occur at a frequency of 9610
214
[38]. For this study, mutations in the rpoB gene were observed in 34
out of 65 (52.3%) of the isolates, of which 79.4% (n=27) of the M.
tuberculosis isolates belonged to TbD12 genotypes. Sixty percent of
the isolates with a mutation in the rpoB gene belonged to the
CAS1_DELHIsub-lineage.TheMIRU-VNTRresultsclearlyshow
that although similar (26 of 36 CAS isolates had .90% similarity in
their MIRU-VNTR types), the isolates were not clones from a
recent outbreak. There was no apparent association between
patients having received previous treatment for TB and mutations
conferring drug-resistance to RIF and INH for CAS1_DELHI sub-
lineages, suggesting that there may be a higher frequency of
circulating drug-resistant CAS1_DELHI isolates in New Delhi.
Other genotypic studies from India [7,18] are based solely on
spoligotypes. In our study, high resolution genotyping, based on
the multiple markers employed, was able to provide clues with
regard to the evolutionary history of the CAS sub-lineages. The
secondary sequence typing approach (gyrA/katG and pncA genes)
revealed a CAS-lineage specific silent C-.T mutation in codon 65
of the pncA gene. This mutation was present in all observed ST’s
within the CAS lineage, except for 2 out of 16 ST26
(CAS1_DELHI) isolates, suggesting that the mutating lineages
are descendents of the ancestral CAS1_DELHI type. Previous
studies [39–41] show that there does not seem to be any
association between this mutation and resistance to PZA. In order
to determine if this mutation is generalizable to CAS isolates from
other geographical locations, isolates from Myanmar (n=15) and
South Africa (n=4) were also analyzed. All isolates from South
Africa and Myanmar, except two isolates from Myanmar
belonging to the ST26 and ST1378 genotypes, had the C-.T
mutation in codon 65 of the pncA gene. This mutation could
potentially be utilized to develop a rapid CAS specific PCR-based
genotyping assay, which could be useful in phylogeographical
studies and in epidemiological investigations of TB outbreaks.
In addition to the silent mutation in codon 65 of the pncA gene,
9 other point-mutations in the pncA gene were observed (Figure 1
and Table 3). The pncA gene codes for the enzyme pyrazinami-
dase, which converts the pro-drug PZA, to its active form. PZA is
one of the cornerstone drugs retained in the treatment of MDR-
TB. Previous studies [42–44] have shown that mutations in the
structural gene or promoter region of pncA, leading to an amino
acid substitution, confer resistance to PZA in 72–97% of the cases.
We have recently shown that a high proportion of South African
MDR M. tuberculosis isolates are resistant to PZA [42]. In this
study, we show that 30.4% of the MDR isolates were also resistant
to PZA. Further studies with systematic testing for PZA are
required to assess if these findings are representative for MDR
isolates from other states in India.
Careful monitoring of circulating strains is required to detect
new and emerging genotypes. Isolates belonging to the CAS1_-
DELHI sub-lineage should be fully characterized with regards to
their level of virulence, transmissibility and mutability to
determine if they share certain characteristics with the hypervir-
ulent and highly transmissible Beijing lineage. The association
between the CAS1_DELHI isolates and drug-resistance observed
for this study may be attributed to a low sample size and the fact
that the isolates were collected from a single hospital in an urban
setting. Thus larger studies, including isolates from more remote
areas, are required in order to fully delineate the association of the
CAS1_DELHI isolates with drug-resistance. Additionally, screen-
ing for the pncA S65S mutation in isolates from other shared-types
of the CAS-lineage may aid in the reconstruction of the
phylogenetic relationships of genotypes within this lineage.
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